Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 27 results:
Author Title Type [ Year] Filters: Keyword is Angiotensin-Converting Enzyme Inhibitors [Clear All Filters]
Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis..
Nephrol Dial Transplant. 38(1), 203-211.
(2023). Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis..
Diabetes Obes Metab. 25(10), 3020-3029.
(2023). Assessment and Management of Hypertension among Patients on Peritoneal Dialysis..
Clin J Am Soc Nephrol. 14(2), 297-305.
(2019).
(2019). Adherence to Treatment, Safety, Tolerance, and Effectiveness of Perindopril/Amlodipine Fixed-Dose Combination in Greek Patients with Hypertension and Stable Coronary Artery Disease: A Pan-Hellenic Prospective Observational Study of Daily Clinical Practice.
Am J Cardiovasc Drugs. 17(5), 391-398.
(2017). Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke..
Clin Exp Hypertens. 39(3), 246-250.
(2017).
(2017). Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence..
Vasc Health Risk Manag. 12, 443-451.
(2016). Current challenges in antihypertensive treatment in the elderly..
Pol Arch Med Wewn. 126(7-8), 540-51.
(2016). Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?.
J Clin Hypertens (Greenwich). 18(8), 828.
(2016). Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?.
Kidney Int. 85(3), 536-46.
(2014). The authors reply..
Kidney Int. 86(4), 855.
(2014). Combined angiotensin inhibition in diabetic nephropathy..
N Engl J Med. 370(8), 778-9.
(2014). Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness..
J Am Soc Hypertens. 8(2), 74-82.
(2014). Association of the optic disc structure with the use of antihypertensive medications: the thessaloniki eye study..
J Glaucoma. 22(7), 526-31.
(2013). Exercise-induced platelet activation in essential hypertension: have we solved the puzzle?.
J Hypertens. 31(9), 1915-6.
(2013).
(2013). Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation..
Liver Int. 30(2), 334-5.
(2010).
(2010).
(2010). Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes..
Angiology. 60(6), 772-9.
(2009). Telmisartan for prevention of cardiovascular events..
N Engl J Med. 360(3), 302; author reply 303.
(2009). Is angioedema a class adverse effect of the angiotensin-converting enzyme inhibitors?.
Ann Allergy Asthma Immunol. 98(5), 502.
(2007). Endothelial function, arterial stiffness and lipid lowering drugs..
Expert Opin Ther Targets. 11(9), 1143-60.
(2007). The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?.
Expert Opin Ther Targets. 11(2), 191-205.
(2007).